Analgesics in Thailand sustains robust value growth in 2026, rising by 2% to THB10,850 million despite slowing momentum compared to the rapid post-pandemic years, and outperforms regional benchmarks due to resilient demand anchored in affordability, lifestyle-driven pain, and digital transformation. This environment is attractive for both established and challenger brands, as fragmentation persists and opportunities emerge from an ageing population, widespread adoption of impulse-friendly sachet formats, and the accelerating shift to digital and social commerce. Success increasingly depends on adapting portfolios to smaller, low-priced packs, engaging consumers via digital-first content and livestream selling, and aligning product positioning with daily mobility and active ageing, rather than relying solely on pharmacy heritage or premium innovation. The landscape is being rapidly redefined by cash-flow-driven purchasing behaviour, high-frequency transactions in convenience channels, and the integration of creator-led marketing with omnichannel retail strategies, making agility and consumer insight critical for defending share and capturing incremental growth.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Thailand with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Thailand, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Thailand report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Thailand?
- Which are the leading brands in Analgesics in Thailand?
- How are products distributed in Analgesics in Thailand?
- How has the regulatory and operating environment for Analgesics changed in Thailand?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Analgesics in Thailand grows steadily as office syndrome and ageing demographics sustain demand
Affordability and sachet culture sustain systemic analgesics as the largest and best performing category
E-commerce and social commerce reshape analgesics as digital channels drive discovery and repeat purchases
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Older adults set to drive demand for mobility-focused pain relief
Sachet economy expected to sustain OTC analgesics growth
Social commerce projected to replace traditional OTC discovery
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Sara and Tylenol retain strength by leveraging pharmacy access and affordability
Agile players gain ground through hydrogel innovation and lifestyle positioning
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies lead as consumer trust and chain expansion sustain dominance
T.Man and Bertram expand topical reach with digital and convenience focus
Digital-first platforms and social commerce accelerate trial for topical brands
Chart 1 Retail Channels 2021-2026
Lifestyle engagement and format innovation replace pharmaceutical formulation as an innovation driver
Tiger Balm, Counterpain, Namman Muay and Pharmica lead recent innovation
Lifestyle-aligned brands secure loyalty while challengers use innovation to disrupt incumbents
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!